Genmab A GMAB
NASDAQ GMAB
$40.08 +0.51 (+1.28%)
As of: Oct 22, 2026 · 12:18 PM EDT

Genmab A (GMAB) Debt Ratio (2025 - 2026)

Updated

Genmab A's (GMAB) Debt Ratio came in at 0.41 for the quarter ended Jun 30, 2026, up 2.9% from the prior quarter.

Analysis

Genmab A (GMAB) Debt Ratio (2025 - 2026) Analysis & Trends

For the year ended Dec 31, 2025, Genmab A's Debt Ratio stood at 0.43.

  • In prior years, Genmab A's Debt Ratio was 0.01 in the year ended Dec 31, 2021 (+12.5%).
  • Quarterly Debt Ratio has run from a low of 0.01 in the quarter ended Dec 31, 2021 to a high of 0.43 in the quarter ended Dec 31, 2025 over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,172.71 Bn 1,141.30 Bn 19.71 Bn 0.39
2 Johnson & Johnson 643.11 Bn 561.64 Bn 17.26 Bn 0.24
3 AbbVie 502.25 Bn 475.37 Bn 12.70 Bn 0.52
4 Merck 375.34 Bn 329.72 Bn 12.21 Bn 0.42
5 Novartis Ag 302.74 Bn 266.73 Bn 11.24 Bn 0.08
6 Astrazeneca 268.89 Bn 242.58 Bn 12.86 Bn 0.28
7 Amgen 242.17 Bn 197.57 Bn 7.24 Bn 0.60
8 Gilead Sciences 193.67 Bn 167.87 Bn 6.22 Bn 0.53
9 Pfizer 172.45 Bn 119.10 Bn 10.94 Bn 0.31
10 Genmab A 2.59 Bn -2.78 Bn 1.07 Bn 0.41
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.41
Mar 31, 2026 0.40
Dec 31, 2025 0.41
API Access

Genmab A Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=GMAB&period=max&api_key=YOUR_API_KEY